Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 331
Appendix D Forum on Emerging Infections Membership and Publications Board on Global Health FORUM ON EMERGING INFECTIONS ADEL MAHMOUD (Chair), President, Merck Vaccines, Whitehouse Station, New Jersey STANLEY LEMON (Vice-Chair), Dean, School of Medicine, The University of Texas Medical Branch, Galveston, Texas DAVID ACHESON, Chief Medical Officer, Center for Food Safety and Applied Nutrition, Food and Drug Administration, Rockville, Maryland STEVEN BRICKNER, Research Advisor, Pfizer Global Research and Development, Pfizer Inc., Groton, Connecticut GAIL CASSELL, Vice President, Scientific Affairs, Eli Lilly & Company, Indianapolis, Indiana GORDON DEFRIESE, Professor of Social Medicine, University of North Carolina, Chapel Hill, North Carolina CEDRIC DUMONT, Medical Director, Department of State and the Foreign Service, Washington, DC JESSE GOODMAN, Deputy Director, Center for Biologics Evaluation and Research, Food and Drug Administration, Rockville, Maryland EDUARDO GOTUZZO, Director, Instituto de Medicina Tropical, “Alexander von Humbolt” Universidad Peruana Cayetano Herdia, Lima, Peru RENU GUPTA, Vice President and Head, U.S. Clinical Research and Development, and Head, Global Cardiovascular, Metabolic, Endocrine, and G.I. Disorders, Novartis Corporation, East Hanover, New Jersey
OCR for page 332
MARGARET HAMBURG, Vice President for Biological Programs, Nuclear Threat Initiative, Washington, DC CAROLE HEILMAN, Director, Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland DAVID HEYMANN, Executive Director, Communicable Diseases, World Health Organization, Geneva, Switzerland JAMES HUGHES, Assistant Surgeon General and Director, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia SAMUEL KATZ, Wilburt C. Davison Professor and Chairman Emeritus, Duke University Medical Center, Durham, North Carolina PATRICK KELLEY, Colonel, Director, Department of Defense Global Emerging Infections System, Walter Reed Army Institute of Research, Silver Spring, Maryland MARCELLE LAYTON, Assistant Commissioner, Bureau of Communicable Diseases, New York City Department of Health, New York, New York JOSHUA LEDERBERG, Raymond and Beverly Sackler Foundation Scholar, The Rockefeller University, New York, New York CARLOS LOPEZ, Research Fellow, Research Acquisitions, Eli Lilly Research Laboratories, Indianapolis, Indiana LYNN MARKS, Global Head of Infectious Diseases, GlaxoSmithKline, Collegeville, Pennsylvania STEPHEN MORSE, Director, Center for Public Health Preparedness, Columbia University, New York, New York MICHAEL OSTERHOLM, Director, Center for Infectious Disease Research and Policy, and Professor, School of Public Health, University of Minnesota, Minneapolis, Minnesota GARY ROSELLE, Program Director for Infectious Diseases, VA Central Office, Veterans Health Administration, Department of Veterans Affairs, Washington, DC DAVID SHLAES, Executive Vice President for Research and Development, Idenix, Cambridge, Massachusetts JANET SHOEMAKER, Director, Office of Public Affairs, American Society for Microbiology, Washington, DC P. FREDRICK SPARLING, J. Herbert Bate Professor Emeritus of Medicine, Microbiology, and Immunology, University of North Carolina, Chapel Hill, North Carolina MICHAEL ZEILINGER, Infectious Disease Team Leader, Office of Health and Nutrition, U.S. Agency for International Development, Washington, DC
OCR for page 333
Liaisons ENRIQUETA BOND, President, Burroughs Wellcome Fund, Research Triangle Park, North Carolina NANCY CARTER-FOSTER, Director, Program for Emerging Infections and HIV/AIDS, U.S. Department of State, Washington, DC EDWARD McSWEEGAN, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland STEPHEN OSTROFF, Associate Director for Epidemiologic Science, National Center for Infectious Diseases. Centers for Disease Control and Prevention, Atlanta, Georgia BOARD ON GLOBAL HEALTH DEAN T. JAMISON (Chair), Senior Fellow, Fogarty International Center, National Institutes of Health YVES BERGEVIN, Chief, Health Section, UNICEF PATRICIA DANZON, Professor, Health Care Systems Department, University of Pennsylvania RICHARD FEACHEM, Interim Secretariat, Global Fund to Fight AIDS, Tuberculosis and Malaria, Geneva NOREEN GOLDMAN, Professor, Office of Population Research, Princeton University, Princeton, New Jersey MARGARET HAMBURG, Vice President for Biological Programs, Nuclear Threat Initiative, Washington, DC GERALD KEUSCH, Director, Fogarty International Center, National Institutes of Health ARTHUR KLEINMAN, Maude and Lillian Presley Professor of Medical Anthropology/ Professor of Psychiatry and Social Medicine, Harvard Medical School ADEL MAHMOUD, President, Merck Vaccines JOHN WYN OWEN, Secretary, Nuffield Trust, London ALLAN ROSENFIELD, Dean, Mailman School of Public Health, Columbia University SUSAN SCRIMSHAW, Dean, School of Public Health, University of Illinois at Chicago Staff JUDITH BALE, Director, Board on Global Health (retired December 2002) STACEY L. KNOBLER, Director, Forum on Emerging Infections MARK S. SMOLINSKI, Senior Program Officer PATRICIA CUFF, Research Associate MARJAN NAJAFI, Research Associate
OCR for page 334
KATHERINE OBERHOLTZER, Project Assistant JASON PELLMAR, Project Assistant PUBLICATIONS The Infectious Etiology of Chronic Diseases in press The Impact of Globalization on Infectious Disease Emergence and Control in press The Resistance Phenomenon in Microbes and Infectious Disease Vectors Implications for Human Health and Strategies for Containmemt 2003 The Emergence of Zoonotic Diseases Understanding the Impact on Animal and Human Health 2002 Considerations for Viral Disease Eradication Lessons Learned and Future Strategies 2002 Biological Threats and Terrorism Assessing the Science and Response Capabilities 2002 Emerging Infectious Diseases from the Global to Local Perspective 2002 Managed Care Systems and Emerging Infections Challenges and Opportunities for Strengthening Surveillance, Research, and Prevention 2000 Antimicrobial Resistance Issues and Options 1998 Orphans and Incentives Developing Technologies to Address Emerging Infections 1997
Representative terms from entire chapter: